IP Library Granted Patent US 8,137,299
Granted Patent B2
US 8,137,299 · App. 12/574,128 · Granted Mar 20, 2012

Wearable ultrafiltration device

Assignee: Fresenius Medical Care Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,299
App. No.
12/574,128
Granted
Mar 20, 2012
Kind
B2
Abstract

An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.

Claims (28)

1. A completely wearable ultrafiltration device comprising:

a shuttle pump adapted to pump blood from a patient's blood vessel;

an ultrafiltration filter that receives blood from the shuttle pump, the ultrafiltration filter comprising a plurality of hollow fibers each having semi porous walls such that excess fluid from the blood moves through the semi porous walls at a rate determined by a magnitude of pressure within the plurality of hollow fibers, the magnitude of pressure being created by the shuttle pump, the completely wearable ultrafiltration device constructed and configured to operate and remove excess fluid while in various three-dimensional orientations while being worn on a portion of a patient's body; and

a fluid bag that receives the removed excess fluid as the excess fluid drains from the ultrafiltration filter.

2. The completely wearable ultrafiltration device of claim 1 , further comprising:

a blood inlet tube that extends from the patient's blood vessel to a shuttle pump input and then from a shuttle pump output to an input of the ultrafiltration filter; and

an anticoagulant pump connected to the blood inlet tube and adapted to infuse anticoagulant from an anticoagulant reservoir into the blood inlet tube.

3. The completely wearable ultrafiltration device of claim 2 , wherein the anticoagulant pump is a piezoelectric pump or a piston pump.

4. The completely wearable ultrafiltration device of claim 1 , wherein the completely wearable ultrafiltration device is adapted to operate on a rechargeable battery's power, the rechargeable battery being completely worn on the patient.

5. The completely wearable ultrafiltration device of claim 1 , further comprising a blood outlet tube, which carries the patient's blood from the blood filter back to the patient's body.

6. An ultrafiltration device comprising:

a blood inlet tube adapted to receive blood from a patient's body;

a shuttle pump that receives blood from the blood inlet tube and pumps the received blood;

a blood ultrafiltration filter that receives blood forced from the shuttle pump, the blood ultrafiltration filter constructed and configured to filter excess fluid from the blood via pores at a rate determined by a pressure within in the ultrafiltration filter and while in various three-dimensional non-stationary orientations; and

a fluid bag in fluid connection with the blood ultrafiltration filter, the fluid bag adapted to collect the excess fluid filtered from the blood;

the ultrafiltration device sized to be completely worn on a portion of the patient's body.

7. The ultrafiltration device of claim 6 , further comprising a blood outlet tube to transport filtered blood from a blood ultrafiltration filter output back to the patient's body.

8. The ultrafiltration device of claim 6 , further comprising means for infusing anticoagulant into the blood inlet tube.

9. The ultrafiltration device of claim 6 , further adapted to comprise a battery for powering the ultrafiltration device.

10. The ultrafiltration device of claim 6 , wherein the ultrafiltration device weighs less than 2 pounds.

11. A method of removing ultrafiltrate from a patient's blood comprising:

obtaining blood from a patient's vessel through a blood inlet tube;

pumping the blood with a shuttle pump into hollow fibers of a blood filter, the hollow fibers having semiporous walls;

filtering excess fluid from the blood, without a dialysate fluid, through pores in the semiporous walls;

directing the filtered excess fluid from the blood filter into a fluid bag while the shuttle pump, the blood filter and the fluid bag are together oriented in various non-stationary three-dimensional orientations.

12. The method of claim 11 , wherein the shuttle pump, the blood filter and the fluid bag are all adapted to be worn together on a portion of a patient's body.

13. The method of claim 11 , wherein the filtering excess fluid from the blood is done at a rate determined by the pressure of the blood within the hollow fibers.

14. The method of claim 11 , further comprising returning blood that exits the blood filter to the patient via a blood outlet tube.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2010
From: FRESENIUS USA, INC.
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 024483/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2010
From: NATIONAL QUALITY CARE, INC.
To: FRESENIUS USA, INC.
Reel/Frame 024160/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2009
From: GURA, VICTOR; RAMBOD, EDMOND
To: NATIONAL QUALITY CARE, INC.
Reel/Frame 023338/0786 →
Continuity (3)
Continuation 10251937 · Sep 19, 2002
Continuation In Part 10085349 · Nov 16, 2001
Related Publication 20100022936A1 · Jan 28, 2010